Comparative Analysis of the ÊºScholasticÊº Recommendations of the AJCC From 2011 for the Surgical Treatment of Cutaneous Melanoma with the Newly Suggested Guidelines for OSMS From the Bulgarian Society For Dermatologic Surgery! by Tchernev, Georgi & Temelkova, Ivanka
 _______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci. 2018 Dec 20; 6(12):2369-2372.                                                                                                                                                2369 
 
ID Design Press, Skopje, Republic of Macedonia 
Open Access Macedonian Journal of Medical Sciences. 2018 Dec 20; 6(12):2369-2372. 
https://doi.org/10.3889/oamjms.2018.511 
eISSN: 1857-9655 
Case Report 
 
 
  
 
Comparative Analysis of the ʺScholasticʺ Recommendations of 
the AJCC From 2011 for the Surgical Treatment of Cutaneous 
Melanoma with the Newly Suggested Guidelines for OSMS From 
the Bulgarian Society For Dermatologic Surgery! 
 
 
Georgi Tchernev
1,2*
, Ivanka Temelkova
1
 
 
1
Medical Institute of Ministry of Interior (MVR), Department of Dermatology, Venereology and Dermatologic Surgery, General 
Skobelev  Nr 79, Sofia, Bulgaria; 
2
Onkoderma-Private Clinic for Dermatologic Surgery, General Skobelev 26 , Sofia, Bulgaria 
 
Citation: Tchernev G, Temelkova I. Comparative 
Analysis of the ʺScholasticʺ Recommendations of the 
AJCC From 2011 for the Surgical Treatment of Cutaneous 
Melanoma with the Newly Suggested Guidelines For 
OSMS From the Bulgarian Society for Dermatologic 
Surgery Open Access Maced J Med Sci. 2018 Dec 20; 
6(12):2369-2372. 
https://doi.org/10.3889/oamjms.2018.511 
Keywords: One step melanoma surgery; Survival 
benefits; AJCC recommendations; Two-step melanoma 
surgery model; Old school; Surgical innovation 
*Correspondence: Georgi Tchernev. Medical Institute of 
Ministry of Interior (MVR), Department of Dermatology, 
Venereology and Dermatologic Surgery, General 
Skobelev  Nr 79, Sofia, Bulgaria; Onkoderma-Private 
Clinic for Dermatologic Surgery, General Skobelev 26, 
Sofia, Bulgaria. E-mail: georgi_tchernev@yahoo.de 
Received: 19-Nov-2018; Revised: 02-Dec-2018; 
Accepted: 03-Dec-2018; Online first: 18-Dec-2018 
Copyright: © 2018 Georgi Tchernev, Ivanka Temelkova. 
This is an open-access article distributed under the terms 
of the Creative Commons Attribution-NonCommercial 4.0 
International License (CC BY-NC 4.0) 
Funding: This research did not receive any financial 
support 
Competing Interests: The authors have declared that no 
competing interests exist 
 
 
 
 
Abstract 
BACKGROUND: The American Joint Committee on Cancer (AJCC) offers a two-stage, often insufficient or so-
called variable model of cutaneous melanoma treatment. This model starts with primary excision and an initial 
operational safety margin of 0.5 cm in all directions, followed by a re-excision with an additional field of 
operational security, determined by histologically established tumor thickness (with or without removal of SLN). 
We present a brand new method of melanoma surgery, the so-called One Step melanoma surgery (OSMS), in 
which cutaneous melanomas (regardless of their thickness) could be removed by single surgical intervention. 
CASE REPORT: We describe a case of a patient with cutaneous melanoma, with postoperatively established 
Breslow’s tumor thickness of 6 mm, operated on the AJCC model within two surgical sessions. The usual primary 
excision was performed with a surgical safety margin of 0.5 cm in all directions, followed by a secondary excision 
with an additional surgical security field of 1.2 cm in all directions (due to the patient's wish for the optimal 
cosmetic result, agreed and approved by the dermatosurgeon performing the manipulation). 
CONCLUSION: The two-stage method for the treatment of melanomas is often insufficient due to: 1) the inability 
(in this case) secondary excision in the face area to be conducted with an additional recommended operational 
security field of 1.5 cm in all directions; and 2) the patient's wish for a better cosmetic result, which should be 
achieved with less surgical security field, resulting in a compromise solution for re-excision with an additional 
surgical field of 1.2 cm in all directions. 
 
 
 
 
 
 
 
 
 
Introduction 
 
At this stage, melanoma surgery is based on 
the recommendations of the American Joint 
Committee of Cancer (AJCC) [1], [2]. One step 
melanoma surgery (OSMS) is a new and innovative 
method that offers a completely different model for the 
treatment of patients with malignant melanoma [3]. Its 
advantage is that on the one hand we have clear and 
precisely defined therapeutic steps that do not lead to 
hesitation and ambiguity, and on the other are 
performed in a single surgical session [3], [4], [5]. 
We present a case of treatment of a patient 
with malignant melanoma based on the 
recommendations of AJCC. It has been attempted to 
fully comply with these recommendations despite the 
anatomical features of the surgical field.  
The advantages and disadvantages of the 
AJCC’s melanoma surgery models are discussed, as 
well as the advantages of the one-step melanoma 
surgery-OSMS, first described in the world according 
to recommendations of the Bulgarian Society for 
Dermatologic Surgery - BULSDS. 
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Case Report 
 
We present a 69-year-old man in good 
general condition. The patient was hospitalized for 
surgical removal of a pigment lesion located in the 
forehead area. The lesion has a 2-year duration within 
which it gradually increases in size (Figures 1a, 1b).  
 
Figure 1: a and b) Clinical view of the melanocytic lesion in the 
forehead area 
 
During the dermatological examination in the 
forehead area, the presence of a dark brown to the 
black melanocytic lesion, a nodular component, and 
an eroded surface was found (Figure 2a).  
 
Figure 2: a) Outlining the 0,5 cm operational security boundaries in 
all directions, preoperative finding; b) Intraoperative finding of the 
lesion removed by elliptical excision; c) Postoperative clinical 
picture of surgical defect closed by single interrupted sutures 
Clinically and dermatoscopically, these 
findings met the requirements for a malignant 
melanocytic lesion. The lesion was removed 
according to the recommendations of the current 
guidelines, with a primary excision with a surgical 
security field of 0.5 cm in all directions (Figure 2b). 
The resulting surgical defect was recovered by a 
single interrupted sutures (Figure 2c). 
Histological verification has shown that it is a 
malignant melanoma nodular type with ulceration and 
size of 12/8 mm, Clark’s IV level, Breslow’s thickness 
6mm, no perivasal and perineural invasion, no 
satellite deposits. Resection lines standing at 5 mm, 
12 mm and 5 mm respectively. Staging showed that it 
is a stage IIC malignant melanoma (T4bN0M0). At the 
time of primary excision, pathologically enlarged 
cervical, pre- and retro-auricular, axillary and inguinal 
lymph nodes were not detected. 
Twenty days later, the patient was 
hospitalized again to conduct a re-excision in the 
forehead area. Due to the specificities of the 
anatomical area and the impossibility to close the 
surgical defect with the necessary tight adaptation of 
the wound edges, the re-excision was performed with 
an operational security field of about 1.2 cm (Figure 
3a, 3b, 3c, 3d and 3e) in all directions instead of the 
recommended, according to AJCC, field of 1.5 cm. 
Therefore, the final field of surgical safety after the two 
excisions was 1.7 cm instead of 2 cm. The surgical 
defect was again closed with single interrupted 
sutures (Figure 3f). The subsequent histological 
verification found the presence of skin with a foreign 
body type granuloma and fibrotic changes in the deep 
dermis. 
 
Figure 3: a) Outlining the 1,2 cm operational security boundaries in 
all directions, preoperative finding before the re-excision; b), c), d) 
and e) Intraoperative finding during re-excision; f) Postoperative 
clinical picture of surgical defects closed by single interrupted 
sutures after re-excision 
 
Immediately before re-excision was 
conducted a consultation with oncology and within the 
secondary excision, removal of the sentinel lymph 
node (SLN) was not recommended. The conduct of 
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Pet scan on the whole body and presentation at local 
specialized oncology center was planned. 
 
 
Discussion 
 
Globally, the application of melanoma surgery 
is guided by the recommendations of the American 
Joint Committee of Cancer (AJCC) [1], [2]. What these 
guidelines postulates, is for a two-stage surgical 
approach where cutaneous melanoma treatment 
always starts with a primary excision with a fixed 
operational security margin of 0.5 cm in all directions 
[1], [2]. The subsequent postoperative histological 
measurement of tumor thickness passes to the 
second stage, namely re-excision [1], [2]. For a more 
detailed presentation of the differences in AJCC and 
OSMS recommendations, we have systematized data 
in tabular form (Table 1 and 2). What unites the two 
treatment models is that excisions and, respectively, 
in the two-stage model- the re-excisions, are 
dependent on the Breslow tumor thickness [1], [2], [3], 
[4], [5], [6], [7]. 
Table 1: AJCC recommendation [2] 
Breslow thickness Recommended surgical margins 
Melanoma in situ 
0.5 cm (primary excision with 0.5 cm in all directions, followed 
by secondary excision ) 
< 1 mm 
0.5 cm primary excision (followed by secondary excision with 
0.5 cm in all directions) 
1.01 - 2.0 mm 
0.5 cm primary excision (followed by secondary excision with 
0.5 cm-1.5 cm/with SLND) 
2 mm - 4 mm 
0.5 cm primary excision (followed by secondary excision with 
1.5 cm in all directions/with SLND) 
> 4 mm  
0.5 cm primary excision (followed by secondary excision with 
1.5 cm in all directions/ without SLND if nodes not enlarged) 
 
It is unclear why, in the AECC 
recommendations, the field of operational safety for 
melanomas with a thickness between 1 and 2 mm 
varies between 1 and 2 cm [1], [3]. Compared to 
them, European guidelines for the treatment of 
malignant melanoma have a clearly defined field of 
operational safety of 2 cm for melanomas with a 
thickness up to 2 mm [8]. 
After an initial excision of 0.5 cm for all 
cutaneous melanomas, according to the AJCC, the 
subsequent re-excision of histological data for 
melanoma in situ (MIS) and MM < 1 mm (for example) 
should be with an additional operational security field 
of 0.5 in all directions (Table 1) [1]. Instead of them, 
OSMS offers in cases of clinical and dermatoscopic 
data for thin melanomas-MIS and MM < 1 mm, to be 
performed a single excision directly with a safety 
margin of 1 cm in all directions (Table 2) [3]. In cases 
where clinical and dermatoscopic data are indicative 
of melanomas less than 1 mm thick, conducting a two-
step operation is not optimal, and that is precisely the 
advantage of OSMS-diagnosis and treatment within 
one surgical session [3]. 
 
Table 2: One step melanoma surgery (OSMS): Tchernev G et al. 
recommendations [3] 
Breslow thickness Recommended surgical margins 
Melanoma in situ 
1.0 cm (clinical/dermatoscopical evaluation obligate/if possibility 
for echographical examination-from benefit) 
< 1 mm 
1.0 cm (clinical/dermatoscopical evaluation obligate/if possibility 
for echographical examination-from benefit ) 
1.01 - 2.0 mm 
1.0 cm (with SLND), (echographical tumour thickness 
measurement preoperatively recommended) 
2 mm- 4 mm 
2.0 cm (with SLND) echographical tumor thickness measurement 
preoperatively recommended 
> 4 mm 
2.0 cm  
a) no enlarged lymph nodes- 2 cm resection is sufficient,  
b) in the presence of enlarged lymph nodes - to be removed 
together with the reexcison of the primary tumorous tissue!  
 
For MM with a thickness above 1 mm (or for 
which dermatoscopy and clinics are not 
categorical/indicative in favor of thin melanoma), the 
AJCC recommendations are again to be started in all 
cases with a primary excision of 0.5 cm in all 
directions [2]. Compared to the AJCC guidelines from 
2011 [2], when the postoperative histologically 
measured thickness indicates a malignant melanoma 
between 1.01 and 2.0 mm, the limits of the 
subsequent re-excision should be between 1 and 2 
cm, with recommendations to be accompanied by 
SLND (Table 1) [2]. Oddly, why in the AJCC 
publication of 2011 [2] this resection field has been 
described that could have varied between 1 and 2 
cm? [3]. Compared to AJCC, European 
recommendations have a fixed final field of 
operational security which, in their view, for 
melanomas, up to 2 mm thick should be 1 cm [8]. 
Within the newly introduced OSMS, all 
cutaneous melanomas (regardless of their thickness) 
can be operated within one surgical session [3], [4], 
[5], [6], [7]. When this thickness is between 1.01 - 2.0 
mm, the operation can again be performed within one 
surgical intervention, with a safety margin of 1 cm in 
all directions combined with SLND (Table 2) [3], [4], 
[5], [6], [7]. Thus, the AJCC's recommendations on the 
final security field and SLND are respected and clearly 
defined but within one intervention [3], [4], [5], [6], [7]. 
For MM between 2-4 mm tumor thickness, the 
AJCC recommends that the final operational safety 
field is 2 cm in all directions, necessarily combined 
with SLND, which overlaps with the OSMS 
recommendations (Table 1 and 2). The difference, in 
this case, comes from the application of the innovative 
solution of the Bulgarian Society for Dermatologic 
Surgery (BULSDS) for one step melanoma surgery 
(OSMS), where preoperative ultrasound measurement 
of tumor thickness allows to save the need for 
secondary excision [4]. Thus, the surgical treatment of 
melanomas is performed with a surgical security field 
of 2 cm in all directions, combined with SLND during 
one surgical session [5]. 
For melanomas with thickness above 4 mm, 
the recommendations of AJCC and OSMS are similar, 
and according to the two models, after the removal of 
the melanocytic lesion, the final safety field should be 
2 cm in all directions and in case of pathologically 
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enlarged lymph nodes to be combined with their 
removal (Table 1 and 2) [1], [2], [3], [4]. 
According to both models (for tumors with a 
thickness above 4 mm), if there is no evidence of 
pathologically enlarged lymph nodes, the excision of 2 
cm is sufficient and SLND is not of paramount 
importance, as draining lymph nodes may not be 
affected due to several different reasons [1], [3]. The 
reason for the lack of involving of the locoregional 
lymph nodes for thicker melanomas could be due to: 
1) the tumor cells have passed the draining lymph 
node but without stopping in it, 2) primary 
hematogenous dissemination has already occurred 
without lymph nodes and pathways being involved, or 
to have 3) accessory parallel lymphatic pathways 
surrounding the guard lymph node [3]. The resulting 
difference between the two types of 
recommendations-OSMS/AJCC-is that the OSMS 
model clearly defines 1) the boundaries of surgical 
security, 2) much stricter with regard to the radical 
combined approach, also involving the conducting of 
SLND and 3) leads to a categorically more complex 
treatment performed within one operational session 
[3], [4]. 
In conclusion, preoperative ultrasound 
measurement of tumor thickness at our patient would 
allow being performed a single surgical intervention 
with a direct field of operational safety of 2 cm in all 
directions without SLND due to a lack of pathological 
enlargement data. 
The presented analysis shows that current 
AJCC guidelines are not always the most optimal and 
acceptable solution in therapeutic and cosmetic terms. 
One step melanoma surgery solves a great deal of the 
problems and fluctuations that exist in the AJCC's 
recommendations. The greatest difference and 
advantage of OSMS versus AJCC is that the 
treatment of cutaneous melanomas is performed with 
one surgical intervention. 
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